MOESM2 of Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

  • René Hurlemann (Contributor)
  • Steffi Riedel-Heller (Contributor)
  • Daniel L.A. Van Den Hove (Contributor)
  • Katie Lunnon (Contributor)
  • Antonio Del Sol (Contributor)
  • Wolfgang Maier (Contributor)
  • Luca Kleineidam (Contributor)
  • Elaine Delvaux (Contributor)
  • Markus Leber (Contributor)
  • Artemis Iatrou (Contributor)
  • Lars M.T. Eijssen (Contributor)
  • Per Hoffmann (Contributor)
  • Michael Wagner (Contributor)
  • Diego Mastroeni (Contributor)
  • Muhammad Ali (Contributor)
  • Roy Lardenoije (Contributor)
  • Rebecca G. Smith (Contributor)
  • Jonathan Mill (Contributor)
  • Adam R. Smith (Contributor)
  • Gunter Kenis (Contributor)
  • Amit Kawalia (Contributor)
  • Tobias Luck (Contributor)
  • Holger Wagner (Contributor)
  • Frank Jessen (Contributor)
  • Bart P.F. Rutten (Contributor)
  • Janou A.Y. Roubroeks (Contributor)
  • Paul Coleman (Contributor)
  • Ehsan Pishva (Contributor)
  • Alfredo Ramirez (Contributor)

Dataset

Description

Additional file 2. All Supplementary Figures (1–12) and descriptions.
Date made availableJan 1 2019
Publisherfigshare Academic Research System

Access Dataset

  • Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood

    Lardenoije, R., Roubroeks, J. A. Y., Pishva, E., Leber, M., Wagner, H., Iatrou, A., Smith, A. R., Smith, R. G., Eijssen, L. M. T., Kleineidam, L., Kawalia, A., Hoffmann, P., Luck, T., Riedel-Heller, S., Jessen, F., Maier, W., Wagner, M., Hurlemann, R., Kenis, G., Ali, M., & 9 othersDel Sol, A., Mastroeni, D., Delvaux, E., Coleman, P. D., Mill, J., Rutten, B. P. F., Lunnon, K., Ramirez, A. & Van Den Hove, D. L. A., Nov 27 2019, In: Clinical Epigenetics. 11, 1, 164.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    68 Scopus citations

Cite this